Article PDF
Avoid common mistakes on your manuscript.
References
Adam, E., Kaufman, R. H., Mirkovic, R. R., Melnick, J. L.: Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis. Obstet. Gynecol.54, 171–173 (1979).
Armstrong, J. A., Evans, A. S., Rao, N., Ho, M.: Viral infections in renal transplant recipients. Infect. Immun.14, 970–975 (1976).
Babiuk, L. A., Rouse, B. T.: Immune control of herpesvirus latency. Can. J. Microbiol.25, 267–274 (1979).
Baringer, J. R.: Herpes simplex virus infection of nervous tissue in animals and man. Progr. Med. Virol.20, 1–26 (1975).
Baringer, J. R., Swoveland, P.: Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab. Invest.30, 230–240 (1974).
Becker, Y., Hadar, J.: Antivirals 1980—An update. Prog. Med. Virol.26, 1–44 (1980).
Blyth, W. A., Hill, T. J., Field, H. J., Harbour, D. A.: Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J. Gen. Virol.33, 547–550 (1976).
Bodian, D.: The virus, the nerve cell, and paralysis. A study of experimental poliomyelitis in the spinal cord. Bull. Johns Hopkins Hosp.83, 1–108 (1948).
Brown, S. M., Subak,-Sharpe J. H., Warren, K. G., Wroblevska, Z., Koprowski, H.: Detection by complementation of defective or uninducible (herpes simplex virus type 1) virus genomes latent in human ganglia. Proc. Natl. Acad. Sci. U.S.A.76, 2364–2368 (1979).
Cappel, R., de Cuyper, F., Rickaert, F.: Efficacy of a nuclei acid free herpetic subunit vaccine. Arch. Virol.65, 15–24 (1980).
Cheeseman, S. H., Rubin, R. H., Stewart, J. A., Tolkoff-Rubin, N. E., Cosimi, A. B., Cantell, K., Gilbert, J., Winkle, S., Herrin, J. T., Black, P. S., Hirsch, M. S.: Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. New Engl. J. Med.300, 1345–1349 (1979).
Chou, S., Gallagher, T. G., Merrigan, T. C.: Controlled clinical trial of intravenous Acyclovir in hearttransplant patients with mucocutaneous herpes simplex infections. Lanceti, 1392–1394 (1981).
Cook, M. L., Stevens, J. G.: Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun.7, 272 to 288 (1973).
Cook, M. L., Stevens, J. G.: Latent herpetic infections following experimental viraemia. J. Gen. Virol.31, 75–80 (1976).
Courtney, R. J., Benyesh-Melnick, M.: Isolation and characterization of a large molecular weight polypeptide of herpes simplex virus type 1. Virology62, 539–551 (1974).
Craig, C. P., Nahmias, A. J.: Different patterns of neurologic involvement with herpes simplex virus type 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J. Infect. Dis.127, 365–372 (1973).
Cupps, T. R., Straus, S. E., Waldmann, T. A.: Successful treatment with Acyclovir of an immunodeficient patient infected simultaneously with multiple Herpesviruses. Amer. J. Med.70, 882–886 (1981).
Dixon, R. A. F., Schaffer, P. A.: Fine structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP 175. J. Virol.36, 189–203 (1980).
Docherty, J. J., Chopan, M.: The latent herpes simplex virus. Bact. Rev.38, 337–355 (1974).
Duff, R., Rapp, F.: Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J. Virol.12, 209–217 (1973).
Field, H. J., Bell, S. E., Ellion, G. B., Nash, A. A., Wildy, P.: Effect of acycloguanosine treatment on acute and latent herpes simplex infections in mice. Antimicrob. Agents Chemother.15, 554–561 (1979).
Field, H. J., Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovirin vitro andin vivo. Antimicrob. Agents Chemother.17, 209–216 (1980).
Field, H. J., Hill, T. J.: The pathogenesis of pseudorabies in mice following peripheral inoculation. J. Gen. Virol.23, 145–157 (1974).
Field, H. J., Wildy, P.: The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. Camb.81, 267–277 (1978).
Field, H. J., Wildy, P.: Recurrent herpes simplex: the outlook for systemic antiviral agents. Brit. Med. J.282, 1821–1822 (1981).
Fong, B. S., Scriba, M.: Use of [125I] deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs. J. Virol.34, 644–649 (1980).
Galasso, G. J.: An assessment of antiviral drugs for the management of infectious diseases in humans. Antiviral Res.1, 73–96 (1981).
Galloway, D. A., Fenoglio, C., Shevchuck, M., McDougall, J. K.: Detection of herpes simplex RNA in human sensory ganglia. Virology95, 265–268 (1979).
Goodman, E. L., Luby, J. P., Johnson, M. T.: Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalis. Antimicrob. Agents Chemother.8, 693–697 (1975).
Goodpasture, E. W.: Herpetic infection, with especial reference to involvement of the nervous system. Medicine (Baltimore)8, 223–243 (1929).
Green, M. T., Courtney, R. J., Dunkel, E. C.: Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun.34, 987–992 (1981).
Green, M. T., Rosborough, J. P., Dunkel, E. C.:In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model. Infect. Immun.34, 69–74 (1981).
Harbour, D. A., Blyth, W. A., Hill, T. J.: Prostaglandins enhance spread of herpes simplex virus in cell cultures. J. Gen. Virol.41, 87–95 (1978).
Hill, T. J., Blyth, W. A.: An alternative theory of herpes simplex recurrence and a possible role for prostaglandins. Lanceti, 397–399 (1976).
Hill, T. J., Harbour, D. A., Blyth, W. A.: Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection. J. Gen. Virol.47, 205–207 (1980).
Hill, T. J., Field, H. J., Roome, A. P. C.: Intra-axonal location of herpes simplex virus particles. J. Gen. Virol.15, 253–255 (1972).
Hilleman, M. R., Larson, V. M., Lehman, E. D., Salerno, R. A., Conrad, P. G., McLean, A. A.: Subunit herpes simplex virus-2 vaccine. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 503–506. New York: Elsevier 1981.
Honess, R. W., Roizmann, B.: Regulation of herpes virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol.14, 8–19 (1974).
Juel-Jensen, B. E., MacCallum, F. O.: Treatment of herpes simplex lesions of the face with idoxuridine: results of a double-blind controlled trial. Brit. Med. J.ii, 987–988 (1964).
Kaufman, H. E.: Local theraphy of herpes simplex virus ocular infections. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 466–477. New York: Elsevier 1981.
Kern, E. R., Overall, J. C., jr., Glasgow, L. A.: Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-B-D-arabinofuranosycytosine and 9-B-D-arabinofuranosyladenine. Antimicrob. Agents Chemother.7, 587–595 (1975).
Kitces, E. N., Morahan, P. S., Twe, J. G., Murray, B. K.: Protection from oral herpes simplex infection by a nucleic acid-free virus vaccine. Infect. Immun.16, 955–960 (1977).
Klein, R. J.: Pathogenetic mechanisms of recurrent herpes simplex virus infections. Arch. Virol.51, 1–13 (1976).
Klein, R. J.: Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. J. Gen. Virol.49, 401–405 (1980).
Klein, R. J., Buimovici-Klein, E., Moser, H., Moucha, R., Hilfenhaus, J.: Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice. Arch. Virol.68, 73–80 (1981).
Klein, R. J., DeStefano, E.: The initiation of the acute herpes simplex virus infection in mice. In preparation (1982).
Klein, R. J., DeStefano, E., Brady, E., Friedman-Kien, A. E.: Experimental skin infection with an acyclovir-resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection. Arch. Virol.65, 237–246 (1980).
Klein, R. J., DeStefano, E., Friedman-Kien, A. E., Brady, E.: Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice. Antimicrob. Agents Chemother.19, 937–939 (1981).
Klein, R. J., Friedman-Kien, A. E.: Latent herpes simplex virus infections in spinal ganglia of mice after treatment with adenine arabinoside and adenine arabinoside monophophosphate. Antimicrob. Agents Chemother.12, 577–581 (1977).
Klein, R. J., Friedman-Kien, A. E., Brady, E.: Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site. Arch. Virol.57, 161–166 (1978).
Klein, R. J., Friedman-Kien, A. E., DeStefano, E.: Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants. Infect. Immun.34, 693–701 (1981).
Klein, R. J., Friedman-Kien, A. E., Yellin, P. B.: Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment. Infect. Immun.20, 130–135 (1978).
Knotts, I. B., Cook, M. L., Stevens, J. G.: Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J. Infect. Dis.130, 16–27 (1974).
Korsager, B., Spencer, E. S., Mardhorst, C. H., Andersen, H. K.: Herpes-virus hominis infections in renal transplant recipients. Scand. J. Inf. Dis.7, 11–19 (1975).
Kristensson, K., Ghetti, B., Wisniewski, H. M.: Study on the propagation of herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res.69, 189–201 (1974).
Kristensson, K., Lycke, E., Sjostrand, J.: Spread of herpes simplex virus in peripheral nerves. Acta Neuropath.17, 44–53 (1971).
Kristensson, K., Vahlne, A., Persson, L. A., Lycke, E.: Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation. J. Neurol. Sci.35, 331–340 (1978).
Kurata, T., Kurata, K., Aoyama, Y.: Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment. Japan. J. Exp. Med.48, 427–435 (1978).
Kutinova, L., Slichtova, V., Vonka, V.: Immunogenicity of subviral herpes simplex virus preparations. Arch. Virol.61, 141–148 (1979).
Kwon, B. S., Gangarosa, L. P., Burch, K. D., de Back, J., Hill, J. M.: Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest. Ophthalmol. Vis. Sci.21, 442–449 (1981).
Lascano, E. F., Berria, M. I.: Histological study of the progression of herpes simplex virus in mice. Arch. Virol.64, 67–79 (1980).
Lofgren, K. W., Stevens, J. G., Marsden, H. S., Subak-Sharpe, J. H.: Temperature-sensitive mutants of herpes simplex virus differ in the capacitiy to establish latent infections in mice. Virology76, 440–443 (1977).
MacCallum, F. O., Juel-Jensen, B. E.: Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulfoxide: results of a double blind-controlled trial. Brit. Med. J.ii, 805–807 (1966).
McLennan, J. L., Darby, G.: Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. J. Gen. Virol.51, 233–243 (1980).
Mertin, J., Stackpole, A.: Anti-PGE antibodies inhibitin vivo development of cell-mediated immunity. Nature294, 456–458 (1981).
Mitchell, C. D., Bean, B., Gentry, S., Groth, K. E., Boen, J. R., Balfour, H. H., Jr.: Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lanceti, 1389–1392 (1981).
Montgomerie, J. Z., Becroft, D. M. O., Crotson, M. C., Doak, P. B., North, J. D. K.: Herpes simplex virus infection after renal transplantation. Lancetii, 867–871 (1969).
Moreschi, G. I., Ennis, F. A.: Prevention of herpes simplex virus infections. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 441–446. New York: Elsevier 1981.
Myers, M. G., Oxman, M. N., Clark, J. E., Arndt, K. A.: Failure of neutralred photodynamic inactivation in recurrent herpes simplex virus infections. New Engl. J. Med.293, 945–949 (1975).
Nagafuchi, S., Oda, H., Mori, R., Taniguchi, T.: Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice. J. Gen. Virol.44, 715–723 (1979).
Nahmias, A. J.: Herpes viruses from fish to man. A search for pathobiologic unity. In:Joachim, H. (ed.), Pathobiology Annual, 153–182. New York: Century Crofts 1972.
Nahmias, A. J., Roizman, B.: Infection with herpes simplex viruses 1 and 2. New Engl. J. Med.289, 667–674; 719–725; 781–789 (1973).
Naraqi, S., Jackson, G. G., Jonasson, O. M.: Viremia with herpes simplex type 1 in adults. Four nonfatal cases, one with features of chicken pox. Ann. Int. Med.85, 165–169 (1976).
Naraqi, S., Jackson, G. G., Jonasson, O., Yamashiroya, H. M.: Prospective study of prevalence, incidence and source of herpesvirus infections in patients with renal allografts. J. Inf. Dis.136, 531–540 (1977).
Nesburn, A. B., Dickinson, R., Radnoti, M.: The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits. Invest. Ophthalmol.15, 726–731 (1976).
Ohashi, Y., Sakaue, Y., Kato, S., Wada, T., Sato, K.: A detergent-soluble extract of virus infected cells free from infectious virus protects mice from lethal herpes simplex virus infection. Biken J.23, 199–204 (1980).
Openshaw, H., Puga, A., Notkins, A. L.: Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation. Fed. Proc.38, 2660 to 2664 (1979).
Openshaw, H., Sekizawa, T., Wohlenberg, C., Notkins, A. B.: The role of immunity in latency and reactivation of herpes simplex viruses. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 289–296. New York: Elsevier 1981.
Overall, J. C., Jr.: Dermatologic diseases. In:Galasso, G. J., Merigan, T. C. (eds.), Antiviral Agents and Viral Diseases of Man, 305–384. New York: Raven Press 1979.
Paine, T. F., Jr.: Latent herpes simplex infection in man. Bact. Rev.28, 472–479 (1964).
Pass, R. W., Whitley, R. J., Whelchel, J. D., Diethelm, A. G., Reynolds, D. W., Alford, C. A.: Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J. Inf. Dis.140, 487–492 (1979).
Pavan-Langston, D., Park, N. H., Hettinger, M.: Ganglionic herpes simplex and systemic acyclovir. Arch. Ophthalmol.99, 1417–1419 (1981).
Pazin, G. J., Armstrong, J. A., Lam, M. T., Tarr, G. C., Janetta, P. J., Ho, M.: Prevention of reactivated herpes simplex infection by human leukocyte interferon. New Engl. J. Med.301, 225–230 (1979).
Pazin, J. P., Ho, M., Janetta, P. J.: Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J. Inf. Dis.138, 405–409 (1978).
Pien, F. D., Smith, T. F., Anderson, C. F., Webel, M. L., Taswell, H. F.: Herpesvirus in renal transplant patients. Transplantation16, 489–495 (1973).
Price, R. W., Khan, A.: Resistance of peripheral autonomic neurons toin vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infect. Immun.34, 571–580 (1981).
Price, R. W., Schmitz, J.: Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy. Infect. Immun.19, 523–532 (1978).
Puga, A., Rosenthal, J. D., Openshaw, H., Notkins, A. L.: Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology89, 102–111 (1978).
Rajcani, J., Kutinova, L., Vonka, V.: Restriction of latent herpes simplex virus infection in rabbits immunized with subviral herpes simplex vaccine. Acta Virol.24, 183–193 (1980).
Rand, K. H., Rasmussen, L. E., Pollard, R. B., Arvin, A., Merigan, T. C.: Cellular immunity and herpesvirus infections in cardiac-transplant patients. New Engl. J. Med.296, 1372–1377 (1977).
Reeves, W. C., Corey, L., Adams, H. G., Vontver, L. A., Holmes, K. K.: Risk of recurrence after first episode of genital herpes. Relation to HSV type and antibody response. New Engl. J. Med.305, 315–319 (1981).
Renis, H. E., Eidson, E. A., Mathews, J., Gray, J. E.: Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. Infect. Immun.14, 571–578 (1976).
Ritchie, D. A., Timbury, M. C.: Herpes viruses and latency: possible relevance of the structure of the viral genome. FEBS Microbiol. Letters9, 67–72 (1980).
Roizman, B.: An inquiry into the mechanism of recurrent herpes infections of man. Perspect. Virol.4, 283–301 (1965).
Rouse, B. T., Babiuk, L. A.: Mechanism of recovery from herpesvirus infections. A review. Can. J. Compar. Med.42, 414–427 (1978).
Rowe, N. H., Brooks, S. L., Young, S. K., Spencer, J., Petrick, T. J., Buchanan, R. A., Drach, J. C., Shipman, C.: A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labials. Oral Surg. Oral Med. Oral Path.47, 142–147 (1979).
Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., Lietman, P. S.: Acyclovir prophylaxis of herpes simplex virus infections. A randomized double-blind, controlled trial in bone-marrow transplant recipients. New Engl. J. Med.305, 63–67 (1981).
Schwartz, J., Whetsell, W. O., Elizan, T. S.: Latent herpes simplex virus infection of mice: infectoius virus in homogenates of latently infected dorsal root ganglia. J. Neuropathol. Exp. Neurol.37, 45–55 (1978).
Scriba, M.: Extraneural localization of herpes simplex virus in latently infected guinea pigs. Nature267, 529–531 (1977).
Scriba, M.: Persistence of herpes simplex virus (HSV) infection in ganglia and peripheral tissue of guinea pigs. Med. Microbiol. Immunol.169, 91–96 (1981).
Scriba, M., Tatzber, F.: Pathogenesis of herpes simplex virus infections in guinea pigs. Infect. Immun.34, 655–661 (1981).
Sekizawa, T., Openshaw, H., Wohlenberg, C., Notkins, A. L.: Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science210, 1026–1028 (1980).
Smith, R. A., Sidwell, R. W., Robins, R. K.: Antiviral mechanisms of action. Ann. Rev. Pharmacol. Toxicol.20, 259–284 (1980).
Spruance, S. L., Crumpacker, C. S., Haines, H., Bader, C., Mehr, K., MacCalman, J., Schnipper, L. E., Klauber, M, R., Overall, J. C., jr.: Ineffectiveness of topical arabinoside 5′-monophosphate in the treatment of recurrent herpes simplex labialis. New Engl. J. Med.300, 1180–1184 (1979).
Stevens, J. G.: Latent characteristics of selected herpesviruses. Adv. Canc. Res.22, 227–256 (1977).
Stevens, J. G., Cook, M. L.: Latent herpes simplex virus in spinal ganglia of mice. Science173, 843–845 (1971).
Stevens, J. G., Nesburn, A. B., Cook, M. L.: Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nature (New Biol.)235, 216–271 (1972).
Svennerholm, B., Vahlne, A., Lycke, E.: Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs. Arch. Virol.69, 43–48 (1981).
Tenser, R. B., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in the infection of the trigeminal ganglion. Virology99, 417–422 (1979).
Tenser, R. B., Miller, R. L., Rapp, F.: Trigeminal ganglion infection by thymidine kinase negative-mutants of herpes simplex virus. Science205, 915–917 (1979).
Tenser, R. B., Ressel, S., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titers and evidence forin vivo complementation. Virology112, 328–341 (1981).
Thompson, T. A., Murray, B. K., Morahan, P. S., Cline, P., and the Collaborative Study Group: Protective studies on several herpes simplex type 1 vaccine preparations in a mouse labial infection model (Abstract) In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 649–650. New York: Elsevier 1981.
Trousdale, M. D., Dunkel, E. C., Nesburn, A. B.: Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest. Ophthalmol. Vis. Sci.19, 1336–1341 (1980).
Walz, M. A., Price, R. W., Notkins, A. L.: Latent infection with herpes simplex virus types 1 and 2: viral reactivationin vivo after neurectomy. Science184, 1185–1187 (1974).
Walz, M. A., Yamamoto, H., Notkins, A. L.: Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature264, 554–556 (1976).
Watson, K., Stevens, J. G., Cook, M. L., Subak-Sharpe, J. H.: Latency competence of thirteen HSV-1 temperature-sensitive mutants. J. Gen. Virol.49, 149–159 (1980).
Wheeler, C. E.: Pathogenesis of recurrent herpes simplex infections. J. Invest. Dermatol.65, 341–346 (1975).
Whitley, R. J., Alford, C. A.: Developmental aspects of selected antiviral chemotherapeutic agents. Ann. Rev. Microbiol.32, 285–300 (1978).
Whitley, R. J., Nahmias, A. J., Visintine, A. M., Fleming, C. L., Alford, C. A.: The natural history of herpes simplex virus infection of mother and newborn. Pediatrics66, 489–494 (1980).
Whitley, R. J., Soong, S. J., Dolin, R., Galasso, G. J., Ch'ien, L. T., Alford, C. A., and the Collaborative Study Group: Adenine arabinoside therapy of biopsyproved herpes simplex encephalitis. New Engl. J. Med.297, 289–294 (1977).
Wildy, P.: The progression of herpes simplex virus to the central nervous system of the mouse. J. Hyg. Camb.65, 173–192 (1967).
Yamamoto, H., Walz, M. A., Notkins, A. L.: Viral-specific thymidine kinase in sensory ganglia of mice infected with herpes simplex virus. Virology76, 866 to 869 (1977).
Author information
Authors and Affiliations
Additional information
With 4 Figures
Rights and permissions
About this article
Cite this article
Klein, R.J. The pathogenesis of acute, latent and recurrent herpes simplex virus infections. Archives of Virology 72, 143–168 (1982). https://doi.org/10.1007/BF01348961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01348961